Capps Kathleen S. sold Enanta Pharmaceuticals Inc. ($ENTA) shares on the open market twice in the last year for a total of about $7,500. Her most recent insider sale occurred on December 5, 2025. These open market transactions rank 11,331st out of 11,678 individual insiders by sale value, well below the average of $8.6 million across 6.37 transactions per insider. Capps Kathleen S. made no open market purchases of $ENTA stock in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Capps Kathleen S. | See Remarks | S | Common Stock | 323 | $14.23 | 8,377.0000 | 28,862,601 | 3.71% | 0.00% |
| Dec. 1, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Capps Kathleen S. | See Remarks | F | Common Stock | 85 | $14.12 | 8,907.0000 | 28,862,601 | 0.95% | 0.00% |
| Dec. 2, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Capps Kathleen S. | See Remarks | S | Common Stock | 207 | $13.96 | 8,700.0000 | 28,862,601 | 2.32% | 0.00% |
| Nov. 25, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Capps Kathleen S. | See Remarks | A | Common Stock | 3163 | $0.00 | 8,992.0000 | 28,862,601 | 54.26% | 0.01% |
| Nov. 25, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Capps Kathleen S. | See Remarks | A | Stock Option (right to buy) | 6325 | $0.00 | 6,325.0000 | 28,862,601 | 9999.99% | 0.02% |